NURS6630 Final Exam questions and answers 2026 update:

NURS6630 Final
Exam questions and
answers 2026
update:
QUESTION 1


What n,will n,the n,PMHNP n,most n,likely n,prescribe n,to n,a n,patient n,with n,psychotic n,aggression n,who n,needs

n, to n,manage n,the n,top-down n,cortical n,control n,and n,the n,excessive n,drive n,from n,striatal n,hyperactivity?


A. n,Stimulants n,B. n,Antidepressants n,C. n,Antipsychotics n,D. n,SSRIs


n, QUESTION n,2


The n,PMHNP n,is n,selecting n,a n,medication n,treatment n,option n,for n,a n,patient n,who n,is n,exhibiting

n, psychotic n,behaviors n,with n,poor n,impulse n,control n,and n,aggression. n,Of n,the n,available n,treatments,

n, which n,can n,help n,temper n,some n,of n,the n,adverse n,effects n,or n,symptoms n,that n,are n,normally n,caused

n, by n,D2 n,antagonism?


A. n,First-generation, n,conventional n,antipsychotics n,B. n,First-generation, n,atypical n,antipsychotics

n, C. Second-generation,
n, conventional
n, antipsychotics
n, D.
n, Second-generation,
n, atypical
n,




n, antipsychotics


QUESTION n,3


The n,PMHNP n,is n,discussing n,dopamine n,D2 n,receptor n,occupancy n,and n,its n,association n,with

n, aggressive n,behaviors n,in n,patients n,with n,the n,student. n,Why n,does n,the n,PMHNP n,prescribe n,a n,standard

dose n,of n,atypical n,antipsychotics?
n,




A. n,The n,doses n,are n,based n,on n,achieving n,100% n,D2 n,receptor n,occupancy. n,B. n,The n,doses n,are n,based

n, on n,achieving n,a n,minimum n,o f n,80% n,D2 n,receptor n,occupancy. n,C. n,The n,doses n,are n,based n,on

, achieving n,60% n,D2 n,receptor n,occupancy. n,D. n,None n,of n,the n,above.
n,

, QUESTION n,4


Why n,does n,the n,PMHNP n,avoid n,prescribing n,clozapine n,(Clozaril) n,as n,a n,first-line n,treatment n,to n,the

patient n,with n,psychosis n,and n,aggression?
n,




A. n,There n,is n,too n,high n,a n,risk n,of n,serious n,adverse n,side n,effects. n,B. n,It n,can n,exaggerate n,the

n, psychotic n,symptoms. n,C. n,Clozapine n,(Clozaril) n,should n,not n,be n,used n,as n,high-dose n,monotherapy.

n, D. n,There n,is n,no n,documentation n,that n,clozapine n,(Clozaril) n,is n,effective n,for n,patients n,who n,are

n, violent.


QUESTION n,5


The n,PMHNP n,is n,caring n,for n,a n,patient n,on n,risperidone n,(Risperdal). n,Which n,action n,made n,by n,the

PMHNP n,exhibits n,proper n,care n,for n,this n,patient?
n,




A. n, Explaining n , to n, the n, patient n , that n , there n , are n, no n, risks n , of n, EPS n , B. n, Prescribing n, the n , patient n , 12
n , mg/dail




C. n,Titrating n,the n,dose n,by n,increasing n,it n,every n,5–7 n,days n,D. n,Writing n,a n,prescription n,for n,a n,higher

dose n,of n,oral n,risperidone n,(Risperdal) n,to n,achieve n,high n,D2 n,receptor n,occupancy
n,




QUESTION n,6


The n,PMHNP n,wants n,to n,prescribe n,Mr. n,Barber n,a n,mood n,stabilizer n,that n,will n,target n,aggressive

n, and n,impulsive n,symptoms n,by n,decreasing n,dopaminergic n,neurotransmission. n,Which n,mood

n, stabilizer n,will n,the n,PMHNP n,select? n,A. n,Lithium n,(Lithane) n,B. n,Phenytoin n,(Dilantin) n,C.

n, Valproate n,(Depakote) n,D. n,Topiramate n,(Topamax)